Influence of Echinacea purpurea intake during pregnancy on fetal growth and tissue angiogenic activity.
暂无分享,去创建一个
[1] Evan R. Ball,et al. Angiogenesis in implantation , 2007, Journal of Assisted Reproduction and Genetics.
[2] A. Koch,et al. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. , 2007, Arthritis and rheumatism.
[3] Paola Viganò,et al. The role of macrophage migration inhibitory factor in maintaining the immune privilege at the fetal–maternal interface , 2007, Seminars in Immunopathology.
[4] T. Johns,et al. Dietary Echinacea purpurea during Murine Pregnancy: Effect on Maternal Hemopoiesis and Fetal Growth , 2006, Neonatology.
[5] Janet Rossant,et al. Endothelial cells and VEGF in vascular development , 2005, Nature.
[6] Anna Lipińska,et al. Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy. , 2005, Journal of diabetes and its complications.
[7] D. Roth-Maier,et al. Efficiency of Echinacea purpurea on performance and immune status in pigs. , 2005, Journal of animal physiology and animal nutrition.
[8] E. Ernst,et al. The Safety of Herbal Medicinal Products Derived from Echinacea Species , 2005, Drug safety.
[9] Sandra C. Miller,et al. Enhancement of natural killer cells and increased survival of aging mice fed daily Echinacea root extract from youth , 2005, Biogerontology.
[10] E. Skopińska-Różewska,et al. The effect of complex herbal remedy on the angiogenic activity of L-1 sarcoma cells, L-1 sarcoma tumour growth, and on the bacterial infection in mice , 2004 .
[11] H. Nordeng,et al. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women , 2004, Pharmacoepidemiology and drug safety.
[12] P. Wei,et al. VEGF, bFGF and their receptors at the fetal-maternal interface of the rhesus monkey. , 2004, Placenta.
[13] K. Münstedt,et al. Angiogenesis and vasculogenesis in pregnancy. , 2003, European journal of obstetrics, gynecology, and reproductive biology.
[14] H. Wagner,et al. Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract undesired effects of chemotherapy—a pilot study , 2002, Phytotherapy research : PTR.
[15] Jan V Slama,et al. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats. , 2002, International immunopharmacology.
[16] M. Nair,et al. Bioactivity of alkamides isolated from Echinacea purpurea (L.) Moench. , 2002, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[17] G. Koren,et al. Can herbal products be used safely during pregnancy? Focus on echinacea. , 2001, Canadian family physician Medecin de famille canadien.
[18] E. Skopińska-Różewska,et al. Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells. , 2000, Oncology reports.
[19] B. G. Hughes,et al. Echinacea-induced cytokine production by human macrophages. , 1997, International journal of immunopharmacology.
[20] J. Tilles,et al. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. , 1997, Immunopharmacology.
[21] G. Aldini,et al. Echinacoside and Caffeoyl Conjugates Protect Collagen from Free Radical-Induced Degradation: A Potential Use of Echinacea Extracts in the Prevention of Skin Photodamage , 1995, Planta medica.
[22] A. Kiderlen,et al. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans. , 1991, International journal of immunopharmacology.
[23] G. Gifford,et al. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. , 1989, Journal of the National Cancer Institute.